Dr. Giridharan Periyasamy holds a Ph.D. in Cancer Biology and Drug Discovery and brings over 22 years of rich experience from academia and industry. He has held pivotal roles at esteemed institutions such as Piramal Life Sciences, Mumbai, CCAMP-NCBS, Bangalore, and A*STAR-Singapore’s Genome Institute and Experimental Drug Discovery Centre. Dr. Periyasamy is an authority in disease biology, discovery genomics, and therapeutic innovation, proficient in setting up advanced in vitro tool-box development and leveraging patient-centric translational platforms for biomarker development and precision health.